Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Novel NanoVelcro Chip Isolates Intact Circulating Tumor Cells for Diagnostic Testing

By LabMedica International staff writers
Posted on 27 Jan 2015
An international team of bioengineers has developed a novel "nanoVelcro" device that removes circulating tumor cells (CTCs) from the blood without damaging them.

Samples of CTCs are regarded as the “liquid biopsy” of a tumor, providing convenient access to all disease sites, including primary tumor and fatal metastases. More...
A method that preserves the integrity of CTCs allows molecular and functional analyses that can guide proper therapeutic intervention.

Investigators at the University of California, Los Angeles (USA) and colleagues at RIKEN Advanced Science Institute (Japan) recently described a novel "nanoVelcro" chip that selectively removes CTCs from the blood. The NanoVelcro Chip is about the size of a postage stamp and is composed of nanowires coated with antibodies that recognize CTCs. When two milliliters of blood are passed through the chip, the tumor cells adhere to the nanowires like Velcro. Efficiency of CTC binding ranges from 40% to 70%. The cancer cells are retained by tiny temperature-responsive polymer brushes inside the device. At 37 degrees Celsius, these polymer brushes stick to the tumor cells, but when cooled to four degrees Celsius, they release them, allowing analysis of the cells.

The investigators were able to successfully demonstrate culture expansion and mutational analysis of CTCs isolated by this purification system. In addition, they adopted the combined use of the Thermoresponsive NanoVelcro system with downstream mutational analysis to monitor the disease evolution of an index non-small-cell lung cancer (NSCLC) patient, highlighting its translational value in managing NSCLC.

“With our new system, we can control the blood’s temperature—the way coffeehouses would with an espresso machine—to capture and then release the cancer cells in great purity,” said senior author Dr. Hsian-Rong Tseng, professor of molecular and medical pharmacology at the University of California, Los Angeles. “We combined the thermoresponsive system with downstream mutational analysis to successfully monitor the disease evolution of a lung cancer patient. This shows the translational value of our device in managing non-small-cell lung cancer with underlying mutations.”

A detailed description of the NanoVelcro Chip was published in the December 13, 2014, online edition of the journal ACS Nano.

Related Links:

University of California, Los Angeles
RIKEN Advanced Science Institute



Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
ESR Analyzer
TEST1 2.0
New
Sperm Quality Analyis Kit
QwikCheck Beads Precision and Linearity Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: Platelets sequester cfDNA during circulation (Murphy L. et al., Science, 2025; DOI: 10.1126/science.adp3971)

Platelets Could Improve Early and Minimally Invasive Detection of Cancer

Platelets are widely recognized for their role in blood clotting and scab formation, but they also play a crucial role in immune defense by detecting pathogens and recruiting immune cells.... Read more

Immunology

view channel
Image: The test could streamline clinical decision-making by identifying ideal candidates for immunotherapy upfront (Xiao, Y. et al. Cancer Biology & Medicine July 2025, 20250038)

Blood Test Predicts Immunotherapy Efficacy in Triple-Negative Breast Cancer

Triple-negative breast cancer (TNBC) is an aggressive subtype lacking targeted therapies, making immunotherapy a promising yet unpredictable option. Current biomarkers such as PD-L1 expression or tumor... Read more

Microbiology

view channel
Image: New diagnostics could predict a woman’s risk of a common sexually transmitted infection (Photo courtesy of 123RF)

New Markers Could Predict Risk of Severe Chlamydia Infection

Chlamydia trachomatis is a common sexually transmitted infection that can cause pelvic inflammatory disease, infertility, and other reproductive complications when it spreads to the upper genital tract.... Read more

Pathology

view channel
image: Researchers Marco Gustav (right) and MD Nic G. Reitsam (left) discuss the study data (Photo courtesy of Anja Stübner/EKFZ)

AI Model Simultaneously Detects Multiple Genetic Colorectal Cancer Markers in Tissue Samples

Colorectal cancer is a complex disease influenced by multiple genetic alterations. Traditionally, studies and diagnostic tools have focused on predicting only one mutation at a time, overlooking the interplay... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.